Literature DB >> 2881987

Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences.

L A Chiodo, B S Bunney.   

Abstract

In the present study, we examined the effects of the cholecystokinin receptor antagonist, proglumide, on the depolarization-induced inactivation of A9 and A10 dopaminergic neurons produced by repeated administration of a classical antipsychotic drug (dopamine receptor antagonist). In addition, we studied the nature of the effects of acute (1-48 hr) and long-term (7 month) treatment with the butyrophenone neuroleptic haloperidol on both the basal firing rate and population response of dopamine-containing neurons in these 2 regions. Acute oral administration of haloperidol (0.5 mg/kg) results, within 1 hr of administration, in an increase in both the firing rate and number of spontaneously active dopamine neurons encountered in both A9 and A10 regions. These effects of a single treatment persist for a minimum of 6 hr and, with respect to firing rate, are not completely normalized for at least 24 hr. In contrast, 7 month continuous treatment with haloperidol reduces the number of spontaneously active DA neurons encountered in both regions in a manner similar to that observed at 21 d. This effect is inferred to be due to the induction of depolarization-induced inactivation of these neurons, since the acute administration of the normally hyperpolarizing, direct-acting dopamine receptor agonist apomorphine (64 micrograms/kg) immediately reverses this reduced number of cells per track to near control levels. This effect appears to be dependent on the continued presence of haloperidol since, when animals treated for 7 months are sampled 14 d after the cessation of drug administration, spontaneous activity is no different from that observed in age-matched controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881987      PMCID: PMC6569064     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  Chronic low-dose haloperidol effects on self-stimulation rate-intensity functions.

Authors:  M R Lynch; R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Alteration in the tranquilizing potency of chlorpromazine in rats exposed chronically to the insecticide, endosulfan.

Authors:  V Paul; E Balasubramaniam; M Kazi
Journal:  Bull Environ Contam Toxicol       Date:  1994-11       Impact factor: 2.151

Review 3.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.

Authors:  A A Grace
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia.

Authors:  Samuel J Mabry; Lesley A McCollum; Charlene B Farmer; Emma S Bloom; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2019-06-04       Impact factor: 4.132

5.  Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.

Authors:  J F Marshall; S J O'Dell; F B Weihmuller
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.

Authors:  R Y Shen; C A Altar; L A Chiodo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

8.  Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.

Authors:  Wendy H Fasulo; Scott E Hemby
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

9.  Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Authors:  A Wolkin; E Duncan; M Sanfilipo; S Wieland; T B Cooper; J Rotrosen
Journal:  J Neural Transm Gen Sect       Date:  1994

10.  Drug discovery in Parkinson's disease-Update and developments in the use of cellular models.

Authors:  Gaia Skibinski; Steven Finkbeiner
Journal:  Int J High Throughput Screen       Date:  2011-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.